Growth Metrics

Trinity Biotech (TRIB) Total Liabilities (2016 - 2025)

Trinity Biotech's Total Liabilities history spans 17 years, with the latest figure at $177.1 million for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 27.93% to $177.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $177.1 million, a 27.93% increase, with the full-year FY2025 number at $177.1 million, up 27.93% from a year prior.
  • Total Liabilities hit $177.1 million in Q4 2025 for Trinity Biotech, up from $149.2 million in the prior quarter.
  • Over the last five years, Total Liabilities for TRIB hit a ceiling of $177.1 million in Q4 2025 and a floor of $81.1 million in Q3 2023.
  • Historically, Total Liabilities has averaged $114.6 million across 5 years, with a median of $116.2 million in 2021.
  • Biggest five-year swings in Total Liabilities: decreased 27.07% in 2022 and later skyrocketed 66.06% in 2024.
  • Tracing TRIB's Total Liabilities over 5 years: stood at $119.2 million in 2021, then decreased by 20.92% to $94.3 million in 2022, then dropped by 11.56% to $83.4 million in 2023, then skyrocketed by 66.06% to $138.5 million in 2024, then rose by 27.93% to $177.1 million in 2025.
  • Business Quant data shows Total Liabilities for TRIB at $177.1 million in Q4 2025, $149.2 million in Q2 2025, and $138.5 million in Q4 2024.